| NCT Number | NCT07618845 |
| Lead Sponsor | Addpharma Inc. |
| Conditions | Chronic Liver Disease (CLD) |
| Enrollment | 24 participants |
| Start Date | 2026-05 |
| Primary Completion | 2026-07 (estimated) |
| Study Completion | 2026-07 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-01 |